证券代码：000776 证券简称：广发证券 公告编号：2026-002 广发证券股份有限公司关于根据一般性授权配售新增 H 股 及发行 H 股可转换债券的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 2026年1月6日（H股交易时段后），广发证券股份有限公司（以下简称"本 公司"）根据一般性授权与配售代理和经办人分别签订了新增H股《配售协议》 与可转换债券《认购协议》，公司拟按每股配售价格18.15港元向符合条件的独 立投资者配售本公司新增发行的219,000,000股H股，并发行本金总金额为2,150 百万港元的可转换为公司H股股份的债券（以下统称"本次发行"）。 本次发行系根据公司2025年第二次临时股东大会以特别决议审议通过的《关 于提请股东大会授予董事会发行H股股份一般性授权的议案》实施，公司股东大 会已授予董事会关于发行H股股份的无条件一般性授权（包括授权董事会于有关 期间作出或授予可能须于有关期间届满后，行使该等权力的售股建议、协议、购 股权及交换或转换股份的权力），新增发行不超过公司2025年第二次临时股东大 会通过时公司已发行境外上市外 ...

证券代码：000776 证券简称：广发证券 公告编号：2026-001 广发证券股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 以上议案同意票 11 票，反对票 0 票，弃权票 0 票。 反对票或弃权票的理由：不适用。 公司根据一般性授权实施 H 股再融资的详情请见与本公告同时披露于巨潮资 讯网站（www.cninfo.com.cn）的《广发证券股份有限公司关于根据一般性授权配 售新增 H 股及发行 H 股可转换债券的公告》。 特此公告。 第十一届董事会第十二次会议决议公告 广发证券股份有限公司（以下简称"广发证券"或"公司"）第十一届董事 会第十二次会议通知于 2026 年 1 月 6 日以专人送达或电子邮件方式发出，会议于 2026 年 1 月 6 日以通讯表决的方式召开。本次董事会应出席董事 11 人，参与表决 董事 11 人。会议内容同时通知了公司高级管理人员。会议的召开符合《公司法》 等有关法律法规和《广发证券股份有限公司章程》的规定。 会议审议通过了以下议案： 一、审议关于公司根据一般性授权实施 H 股再融资的议案 广发证券股份有限公 ...

Market Overview - The US stock market closed higher, with the Dow Jones and S&P 500 indices reaching all-time closing highs. The S&P 500 rose by 0.62%, the Nasdaq increased by 0.65%, and the Dow Jones gained 0.99% [3] - The core drivers of the market were semiconductor and AI-related stocks, particularly following announcements from Nvidia's CEO regarding new AI processors and storage technology [3] - Semiconductor stocks performed exceptionally well, with SanDisk surging over 27%, Western Digital up 17%, Seagate Technology rising 14%, and Micron Technology increasing by 10% [3] - The Philadelphia Semiconductor Index rose by 2.75%, marking a historical record with a cumulative gain of approximately 8% in the first three trading days of the year [3] Technology Sector - Large tech stocks showed mixed performance, with Amazon leading at a 3.38% increase, followed by Microsoft at 1.20%. However, Tesla fell sharply by 4.14%, and Nvidia declined by 0.47% [3] - Chinese concept stocks faced pressure, with the Nasdaq Golden Dragon China Index dropping by 0.78%. Notable movements included a 70.83% surge in Zhongchi Chefu and a 3.18% increase in ASE Technology [4] Commodity Market - Gold prices continued to rise, with spot gold increasing by 0.8% to $4485.39 per ounce [5] - International oil prices retreated, with light crude oil futures for February delivery falling by 2.04% to $57.13 per barrel [5] Regulatory Developments - The Chinese Ministry of Commerce announced stricter export controls on dual-use items to Japan, effective immediately, to safeguard national security [6] - The People's Bank of China outlined its monetary policy for 2026, emphasizing a moderately loose approach and support for economic development and financial stability [6] Financial Sector Insights - Financial institutions anticipate an improvement in market liquidity due to increased credit issuance and fiscal fund allocation at the beginning of the year [9] - Analysts suggest that the Shanghai Composite Index may experience slight upward fluctuations, urging investors to monitor macroeconomic data and policy changes closely [9]

Core Viewpoint - The market is experiencing a resurgence, with significant trading volumes and a bullish sentiment, particularly in the brokerage and fintech sectors, indicating a potential for further growth [3][5][21] Market Performance - The trading volume has consistently exceeded 2.5 trillion, suggesting a strong market interest and participation [3][21] - Major indices such as the CSI 500 and CSI 300 have shown notable increases, with the CSI 500 rising by 2.13% and the CSI 300 by 1.55% on recent trading days [6] Sector Analysis - The resurgence in the brokerage sector is attributed to a combination of factors, including the performance of insurance stocks and a shift in market dynamics towards larger brokerage firms [5][12] - The leading brokerage stocks have outperformed smaller firms, indicating a shift in market focus towards established players [7][12] Trading Dynamics - The correlation between trading volume and brokerage stock performance suggests that high trading activity is beneficial for the sector, although there is a caution against over-reliance on market sentiment [10][13] - Recent data indicates that while IPO activities have increased, the primary revenue for brokerages still relies heavily on investment and brokerage income, making them sensitive to market fluctuations [12] Institutional Investment - Institutional investors, particularly insurance funds, are significantly increasing their positions, indicating a long-term bullish outlook on the market [18] - The current market dynamics are characterized by a focus on value rather than speculative trading, with institutions leading the charge in driving market sentiment [19][21] Future Outlook - The market is expected to continue benefiting from three main driving forces: the appeal of RMB assets, global tech trends, and the consolidation of strong industries [19][21] - The ongoing influx of capital from outside investors suggests that even if indices do not rise significantly, there will still be opportunities for profitable trades within specific sectors [19]

每经AI快讯，超捷股份发布公告称，2026年1月6日，超捷股份接受广发证券等投资者调研，公司董事 会秘书、财务总监李红涛等人参与接待，并回答了投资者提出的问题。 每经头条（nbdtoutiao）——原指导价34.99万的宝马裸车价22.5万元，多家车企还补贴购置税！2026开 年车市火爆，销售从早到晚忙到没空吃饭 （记者 王晓波） ...

Core Viewpoint - Chinese enterprises are embracing a new global upcycle in the excavator market, with overseas excavator sales recovering from -15% in January 2025 to +14% in October 2025, indicating a synchronized global demand recovery [1] Group 1: Market Insights - Japan's construction machinery demand remains resilient despite a significant drop in downstream demand post-bubble economy, with excavator ownership only declining by 30% [2] - In Japan, domestic sales are decoupling from real estate, leading to a stable sales volume, with a shift towards rental and second-hand export models [2] - China's excavator operating hours are still at a high level, providing a buffer for demand, supported by replacement needs and decoupling from real estate [2] Group 2: U.S. Market Dynamics - The U.S. market faces a long-term shortage of excavator ownership, with stock replacement driving demand, supported by both residential and non-residential investments [3] - Future growth drivers include structural support from AI data center infrastructure, the return of U.S. manufacturing boosting large-scale infrastructure growth, and potential stimulation of the housing market following Federal Reserve interest rate cuts [3] - Historical insights from Komatsu's entry into the U.S. market highlight the importance of macro factors, quality, company culture, and localization in overcoming market barriers [3] - Chinese manufacturers are positioned to capitalize on the shift of U.S. construction machinery from premium brands to more general industrial products, leveraging their supply chain advantages and manufacturing efficiency [3] Group 3: Asia, Africa, and Latin America Market - The Asia, Africa, and Latin America markets are primarily driven by mining and energy sectors, with Chinese brands capturing over 40% of the excavator market share in these regions by 2023 [4] - China's infrastructure investment is effectively replacing energy imports from these regions, indicating a strategic link between excavator exports and infrastructure development [4] - The potential for new excavator markets to grow by 60% exists if the share of second-hand excavators from Europe and the U.S. in these regions decreases from 50% to 20% [4] - Chinese enterprises are transitioning from commodity exports to capital exports, establishing local manufacturing in Indonesia to enhance market share and create new pathways into developed countries [4] Group 4: Investment Recommendations - Recommended stocks include SANY Heavy Industry (600031), XCMG Machinery (000425), Zoomlion Heavy Industry (000157), LiuGong Machinery (000528), and Hengli Hydraulic (601100) [4]

Group 1 - The EU carbon tariff will officially be implemented on January 1, 2026, initially affecting industries such as cement, steel, aluminum, fertilizers, electricity, and hydrogen, with potential expansion to chemicals, plastics, ceramics, paper, and organic basic chemicals by 2027 [1] - The current EU ETS carbon price is approximately €80-90 per ton, which is about 13 times higher than China's current carbon price, significantly increasing the cost of exports to the EU [1] - Companies are encouraged to focus on reducing carbon emissions and adapting to carbon tariffs through the circular economy, particularly in sectors like recycled resources, recycling systems, green steam, and green methanol [1] Group 2 - Recent debt resolution actions by listed companies, such as Chuangye Environmental and Mongolian Grass Ecology, indicate a rapid advancement in local debt resolution processes [2] - Local governments are optimizing cash flow through one-time payments of historical debts, early termination of PPP projects, and debt restructuring, which is expected to enhance the market value of many environmental companies [2] - Companies with significant accounts receivable, particularly from government-funded projects, are likely to see notable improvements in market value and profit recovery, especially in solid waste, water services, sanitation, ecological restoration, and water treatment sectors [2] Group 3 - High dividend assets remain attractive, with environmental companies achieving significant excess returns despite a weaker overall dividend environment in 2025 [3] - Notable stock price increases for companies such as China Everbright Environment and Huaneng Environment, with annual growth rates of 31.7%, 26.3%, 46.7%, and 30.6% respectively [3] - The expectation of continued dividend increases is supported by reduced funding needs due to fewer new project orders, making companies like Huaneng Environment, Shanghai Industrial Holdings, and others worthy of attention [3]

Group 1 - Chinese brokerage stocks collectively rose, with Guolian Minsheng up 5.16% at HKD 5.5, Guotai Junan up 4.68% at HKD 17.91, CITIC Securities up 4.41% at HKD 29.82, CICC up 3.91% at HKD 21.26, and GF Securities up 3.19% at HKD 19.09 [1] - The Shanghai Composite Index broke the 4000 mark, achieving a 12-day winning streak, the longest in 33 years [1] - Goldman Sachs released a macro report titled "China 2026 Outlook: Exploring New Momentum," recommending overweight positions in Chinese stocks for 2026, with expectations of a 15% to 20% annual increase in the Chinese stock market for 2026 and 2027, supported by 14% and 12% earnings growth and approximately 10% valuation re-rating [1] Group 2 - Zhongyuan Securities indicated that 2026, as the starting year of the 14th Five-Year Plan, is expected to see a relatively strong overall performance in the capital market, with the securities industry continuing in its upward cycle [2] - The first quarter of 2026 is anticipated to have relatively light year-on-year pressure on the operating performance of listed brokerages, suggesting a period of consolidation at current low levels to prepare for new investment opportunities [2] - Guojin Securities recommended focusing on undervalued brokerages for potential rebound opportunities during the spring market rally, particularly those with high AH premium rates and thematic investments [2]

Group 1 - Chinese brokerage stocks collectively rose, with notable increases: Guolian Minsheng up 5.16% to HKD 5.5, Guotai Junan up 4.68% to HKD 17.91, CITIC Securities up 4.41% to HKD 29.82, CICC up 3.91% to HKD 21.26, and GF Securities up 3.19% to HKD 19.09 [1] - The Shanghai Composite Index surpassed the 4000 mark, achieving a 12-day winning streak, the longest in 33 years [1] - Goldman Sachs released a macro report titled "China 2026 Outlook: Exploring New Momentum," recommending an overweight position in Chinese stocks for 2026, with expectations of a 15% to 20% annual increase in the Chinese stock market for 2026 and 2027, supported by 14% and 12% earnings growth and approximately 10% valuation re-rating [1] Group 2 - Zhongyuan Securities indicated that 2026, as the first year of the 14th Five-Year Plan, is expected to see a relatively strong performance in the capital market, with the securities industry continuing in its upward cycle [2] - The first quarter of 2026 is anticipated to have lighter year-on-year pressure on the operating performance of listed brokerages, suggesting a period of consolidation at current low levels to prepare for new investment opportunities [2] - Guojin Securities recommended focusing on undervalued brokerages for potential rebound opportunities during the spring market rally, particularly those with high AH premium rates and themes of mergers and acquisitions [2]

Core Viewpoint - The Chinese traditional medicine industry is experiencing significant growth driven by policy support and increasing health demands, with a focus on balancing tradition and innovation [1] Group 1: Company Strategy - Jilin Aodong Pharmaceutical Group Co., Ltd. adopts a dual-driven strategy of "medicine health + financial capital" to modernize traditional Chinese medicine [1] - The company has established a robust capital collaborative network, holding 20.11% of Guangfa Securities and being a major shareholder in several pharmaceutical companies, which supports its main business [2][3] - Financial returns from investments in Guangfa Securities contributed 12.43 billion yuan and 17.49 billion yuan in 2023 and 2024 respectively, providing continuous financial support for the pharmaceutical business [3] Group 2: Financial Empowerment - The financial layout allows Jilin Aodong to maintain stable and abundant returns, which are reinvested into the pharmaceutical sector to alleviate the high risks and long cycles of research and development [3] - The company emphasizes a principle of "main business first, financial empowerment," ensuring that financial gains are directed back to support the core pharmaceutical operations [3] Group 3: Technological Innovation - Jilin Aodong places technological innovation at the core of its strategy, focusing on the research of key raw materials and advancing in fields like anti-aging and regenerative medicine [5] - The company has developed a closed-loop industrial chain around the breeding, processing, and quality control of deer antler, ensuring the quality and traceability of raw materials [5][6] - The implementation of modern technology in traditional practices is seen as essential for unlocking the core value of traditional Chinese medicine [5][6] Group 4: Industry Development - The modernization of traditional Chinese medicine is supported by national policies aimed at enhancing quality, digital transformation, and new drug development [4] - Jilin Aodong aims to reshape production factors through technological innovation, transitioning from resource-dependent to innovation-driven models [6] - The company is committed to continuous investment in research and development, enhancing its intelligent layout across the entire industrial chain, and maintaining its heritage as a time-honored brand [7]